Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2

• Published in: Malaria journal Vol. 16; no. 1; p. 58
• Main Authors: Taylor, Diane Wallace, Bobbili, Naveen, Khadka, Vedbar S, Quakyi, Isabella A, Leke, Rose G F
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.02.2017; BioMed Central
• Subjects: Adolescent; Adult; Age; Age composition; Aged; Aged, 80 and over; Analysis; Antibodies; Antibodies, Protozoan - blood; Antibody response; Antigens; Antigens, Protozoan - blood; Antigens, Protozoan - immunology; Blood & organ donations; Cameroon - epidemiology; Child; Child, Preschool; Children; Cross-Sectional Studies; Diagnosis; Endemic Diseases; Epitopes; Female; Histidine; Human diseases; Humans; Immune response (humoral); Immunoglobulin G; Immunoglobulin M; Immunoglobulin M - blood; Immunoglobulins; Lymphocytes T; Malaria; Malaria, Falciparum - epidemiology; Malaria, Falciparum - immunology; Male; Merozoite Surface Protein 1 - blood; Microscopy; Middle Aged; Parasites; Plasmodium falciparum; Prediction models; Pregnancy; Proteins; Protozoan Proteins - blood; Protozoan Proteins - immunology; Recombinants; Specificity; Studies; United States; Vector-borne diseases; Women; Young Adult; Cameroon; United States > US; India; Plasmodium falciparum; Rapid diagnostic tests; HRP-II; Histidine-rich protein II; Malaria; Antibodies; Diagnosis; HRP2
• ISSN: 1475-2875; 1475-2875
• DOI: 10.1186/s12936-017-1704-4

Diagnosis of Plasmodium falciparum is often based on detection of histidine-rich protein 2 (HRP2) in blood. Most HRP2-based assays have high sensitivity and specificity; however, authors have suggested that antibodies (Ab) to HRP2 could reduce assay sensitivity. This study sought to characterize the antibody response to HRP2 with respect to prevalence, class, subclass, affinity, and age distribution in Cameroonian children and adults residing in an area with high P. falciparum transmission. Plasma samples from 181 Cameroonian children and adults who had been repeatedly exposed to P. falciparum and 112 samples from American adults who had never been exposed were tested for IgG Ab to HRP2. For comparison, Ab to the merozoite antigens MSP1, MSP2, MSP3 and the pregnancy-associated antigen VAR2CSA were measured using a multiplex bead-based assay. In addition, 81 plasma samples from slide-positive individuals were screened for IgM Ab to HRP2. As expected, children and adults had IgG Ab to MSP1, MSP2 and MSP3, antibody levels increased with age, and only women of child-bearing age had Ab to VAR2CSA; however, no convincing evidence was found that these individuals had an acquired antibody response to HRP2. That is, using two sources of recombinant HRP2, identical results were obtained when plasma from 110 Cameroonian adults and 112 US adults were screened for IgG Ab. Further studies showed that antibody prevalence and levels did not increase with age in Cameroonians between ages 5 and >80 years. Although a few samples from slide-positive Cameroonians had IgM values slightly above the American cut-off, it was unclear if the individuals had a true IgM response to HRP2 or if the values were due to non-specific binding from elevated immunoglobulin levels associated with infection. Data from prediction models showed a paucity of Class II T cell epitopes in HRP2. These data support the conclusion that most individuals in malaria-endemic areas do not produce an acquired humoral response to HRP2. The absence of Ab helps explain why HRP2-based assays are able to detect nanogram amounts of HRP2 and why HRP2 continues to circulate for a long time after parasite clearance.